(EXC) Exelon - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30161N1019

Electricity, Natural Gas, Transmission, Distribution

Dividends

Dividend Yield 3.65%
Yield on Cost 5y 6.50%
Yield CAGR 5y -0.20%
Payout Consistency 93.4%
Payout Ratio 56.9%
Risk via 10d forecast
Volatility 19.2%
Value at Risk 5%th 31.0%
Relative Tail Risk -1.54%
Reward TTM
Sharpe Ratio 0.84
Alpha 14.73
CAGR/Max DD 0.28
Character TTM
Hurst Exponent 0.393
Beta 0.010
Beta Downside 0.062
Drawdowns 3y
Max DD 21.11%
Mean DD 7.08%
Median DD 6.82%

Description: EXC Exelon December 03, 2025

Exelon Corporation (NASDAQ:EXC) is a Chicago-based utility holding company that operates regulated electricity and natural-gas businesses, handling the purchase, transmission, distribution, and retail sale of power and gas to a broad customer base that includes residential, commercial, industrial, governmental, public-authority, electric-railroad, and transportation users.

In its most recent fiscal year, Exelon reported adjusted earnings per share of roughly $3.20 and a dividend yield near 4.5%, reflecting its stable cash-flow profile; the company’s regulated rate base sits at approximately $70 billion, underpinning its capacity to fund capital projects and maintain a strong credit rating.

Key economic drivers for Exelon include the ongoing shift toward decarbonization, which is prompting increased investment in renewable generation and grid modernization, as well as interest-rate trends that affect the cost of financing its extensive infrastructure portfolio; sector-wide, demand growth for reliable, low-carbon electricity remains a tailwind for regulated utilities.

For a deeper dive into EXC’s valuation metrics and peer comparison, see ValueRay’s analyst toolkit.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (2.82b TTM) > 0 and > 6% of Revenue (6% = 1.46b TTM)
FCFTA -0.01 (>2.0%) and ΔFCFTA -0.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -2.45% (prev 2.79%; Δ -5.24pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.06 (>3.0%) and CFO 6.44b > Net Income 2.82b (YES >=105%, WARN >=100%)
Net Debt (47.48b) to EBITDA (8.94b) ratio: 5.31 <= 3.0 (WARN <= 3.5)
Current Ratio 0.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (1.01b) change vs 12m ago 0.90% (target <= -2.0% for YES)
Gross Margin 42.48% (prev 40.72%; Δ 1.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 22.15% (prev 21.61%; Δ 0.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 2.60 (EBITDA TTM 8.94b / Interest Expense TTM 2.05b) >= 6 (WARN >= 3)

Altman Z'' 0.85

(A) -0.01 = (Total Current Assets 9.23b - Total Current Liabilities 9.82b) / Total Assets 113.54b
(B) 0.07 = Retained Earnings (Balance) 7.39b / Total Assets 113.54b
(C) 0.05 = EBIT TTM 5.31b / Avg Total Assets 109.80b
(D) 0.33 = Book Value of Equity 28.24b / Total Liabilities 85.43b
Total Rating: 0.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 49.63

1. Piotroski 4.0pt
2. FCF Yield -1.69%
3. FCF Margin -6.56%
4. Debt/Equity 1.76
5. Debt/Ebitda 5.31
6. ROIC - WACC (= 2.53)%
7. RoE 10.23%
8. Rev. Trend 13.31%
9. EPS Trend 6.16%

What is the price of EXC shares?

As of December 08, 2025, the stock is trading at USD 43.81 with a total of 7,619,766 shares traded.
Over the past week, the price has changed by -4.11%, over one month by -4.37%, over three months by +2.73% and over the past year by +21.27%.

Is EXC a buy, sell or hold?

Exelon has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold EXC.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 9
  • Sell: 2
  • Strong Sell: 1

What are the forecasts/targets for the EXC price?

Issuer Target Up/Down from current
Wallstreet Target Price 49.8 13.6%
Analysts Target Price 49.8 13.6%
ValueRay Target Price 48.1 9.9%

EXC Fundamental Data Overview November 26, 2025

Market Cap USD = 46.69b (46.69b USD * 1.0 USD.USD)
P/E Trailing = 16.5699
P/E Forward = 16.129
P/S = 1.9201
P/B = 1.6409
P/EG = 2.095
Beta = 0.553
Revenue TTM = 24.32b USD
EBIT TTM = 5.31b USD
EBITDA TTM = 8.94b USD
Long Term Debt = 46.67b USD (from longTermDebt, last quarter)
Short Term Debt = 3.25b USD (from shortTermDebt, last quarter)
Debt = 49.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 47.48b USD (from netDebt column, last quarter)
Enterprise Value = 94.17b USD (46.69b + Debt 49.53b - CCE 2.05b)
Interest Coverage Ratio = 2.60 (Ebit TTM 5.31b / Interest Expense TTM 2.05b)
FCF Yield = -1.69% (FCF TTM -1.59b / Enterprise Value 94.17b)
FCF Margin = -6.56% (FCF TTM -1.59b / Revenue TTM 24.32b)
Net Margin = 11.60% (Net Income TTM 2.82b / Revenue TTM 24.32b)
Gross Margin = 42.48% ((Revenue TTM 24.32b - Cost of Revenue TTM 13.99b) / Revenue TTM)
Gross Margin QoQ = 43.07% (prev 40.72%)
Tobins Q-Ratio = 0.83 (Enterprise Value 94.17b / Total Assets 113.54b)
Interest Expense / Debt = 1.09% (Interest Expense 538.0m / Debt 49.53b)
Taxrate = 15.05% (155.0m / 1.03b)
NOPAT = 4.51b (EBIT 5.31b * (1 - 15.05%))
Current Ratio = 0.94 (Total Current Assets 9.23b / Total Current Liabilities 9.82b)
Debt / Equity = 1.76 (Debt 49.53b / totalStockholderEquity, last quarter 28.11b)
Debt / EBITDA = 5.31 (Net Debt 47.48b / EBITDA 8.94b)
Debt / FCF = -29.77 (negative FCF - burning cash) (Net Debt 47.48b / FCF TTM -1.59b)
Total Stockholder Equity = 27.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.48% (Net Income 2.82b / Total Assets 113.54b)
RoE = 10.23% (Net Income TTM 2.82b / Total Stockholder Equity 27.57b)
RoCE = 7.16% (EBIT 5.31b / Capital Employed (Equity 27.57b + L.T.Debt 46.67b))
RoIC = 5.94% (NOPAT 4.51b / Invested Capital 75.99b)
WACC = 3.41% (E(46.69b)/V(96.22b) * Re(6.05%) + D(49.53b)/V(96.22b) * Rd(1.09%) * (1-Tc(0.15)))
Discount Rate = 6.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.70%
Fair Price DCF = unknown (Cash Flow -1.59b)
EPS Correlation: 6.16 | EPS CAGR: -1.21% | SUE: 3.61 | # QB: 1
Revenue Correlation: 13.31 | Revenue CAGR: -9.21% | SUE: 0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.84 | Chg30d=-0.042 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=2.84 | Chg30d=+0.003 | Revisions Net=+8 | Growth EPS=+5.3% | Growth Revenue=+3.8%

Additional Sources for EXC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle